Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | N/A | NA0587 | IM / LA |
Site: Pain at Injection Site-Mild, Additional Details: Patient was provided verbal and written consent in Spanish for both the influenza and COVID-19 vaccinations for which they had requested at the POS. Prior to administration, verbal/written consent was confirmed. After administration of both vaccines, the patient stated they only wanted the influenza vaccine. No adverse reactions were observed following the COVID-19 vaccine administration. Patient was advised to stay near pharmacy for 15 minutes for observation. , Other Vaccines: VaccineTypeBrand: Fluzone High Dose 2025-2026; Manufacturer: Sanofi-Pasteur; LotNumber: U8859CA; Route: Intramuscular; BodySite: L-arm; Dose: 00; VaxDate: 10/31/2025
No known drug allergies